---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-023723"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2025-02-20T23:59:59+00:00"
generated_at: "2026-05-26T10:00:29.984739+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Pediatrix Q4 net income $30M, Adjusted EPS $0.51, revenue up to $502M

## Summary
- GAAP EPS $0.36 (vs $1.50 loss Q4 2023); Adjusted EPS $0.51 (vs $0.32).
- Net revenue $502M, up from $496M; same-unit revenue grew 8.7%.
- Adjusted EBITDA $68.7M (vs $50.8M); portfolio restructuring completed by Dec 31, 2024.
- Preliminary 2025 Adjusted EBITDA guidance $215M-$235M.
- Cash from operations $134.8M; total debt $616M; no revolver borrowings.

## SEC filing metadata
- accession: 0000950170-25-023723
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2025-02-20T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000095017025023723/0000950170-25-023723-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000095017025023723/md-20250220.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-023723
- JSON: https://secwatch.observer/filing/0000950170-25-023723.json
- Plain text: https://secwatch.observer/filing/0000950170-25-023723.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.